VERAVAS, Inc.

VERAVAS, Inc. is a leading innovator in the medical and diagnostic laboratories sector, dedicated to making early disease detection possible. VERAVAS focuses on the development of advanced clinical diagnostics, particularly in the early-stage detection of Alzheimer’s disease and other neurological conditions. Their proprietary VeraBIND™ technology transforms challenging sample types into measurable biomarkers, enabling earlier and more accurate disease detection, along with the creation of innovative diagnostic tests.

Located at 111 Congress Avenue, Suite 500, Austin, TX 78701, US (Primary address), and with an additional location at 3510 Hopkins Pl N, Oakdale, Minnesota 55128, US, VERAVAS is committed to improving patient outcomes through high-value diagnostic solutions. The VeraBIND Tau assay is a first-in-class, blood-based test that measures the pathological activity of hyperphosphorylated tau in blood samples, which can aid in the diagnosis of Alzheimer's disease in cognitively normal individuals or those experiencing cognitive impairment. VERAVAS continues to expand its capabilities, ensuring improved patient access and non-invasive sample collections.

VERAVAS remains at the forefront of biotechnology and laboratory medicine, offering a range of specialized services including assay development and molecular diagnostics. The company specializes in addressing critical healthcare challenges such as Lyme disease, Celiac Disease, and various infectious and neurodegenerative diseases. VERAVAS is dedicated to providing innovative solutions that transform early disease detection and patient care. Manager, we invite you to create a customized and exclusive company showcase and product listing on our platform.